Royal Bank of Canada’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6646 |
|
|
2025
Q1 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6429 |
|
|
2024
Q4 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6400 |
|
|
2024
Q3 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6422 |
|
|
2024
Q2 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6664 |
|
|
2024
Q1 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6568 |
|
|
2023
Q4 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6599 |
|
|
2023
Q3 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6596 |
|
|
2023
Q2 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6806 |
|
|
2023
Q1 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6675 |
|
|
2022
Q4 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6772 |
|
|
2022
Q3 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6967 |
|
|
2022
Q2 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 6906 |
|
|
2022
Q1 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 7245 |
|
|
2021
Q4 | $0 | Hold |
2,475
| – | – | ﹤0.01% | 7107 |
|
|
2021
Q3 | $1K | Buy |
2,475
+2,469
| +41,150% | +$998 | ﹤0.01% | 6932 |
|
|
2021
Q2 | $0 | Buy |
+6
| New | – | ﹤0.01% | 6954 |
|